Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecular Diversity|May 14, 2026
Unraveling the molecular landscape and therapeutic strategies for acute kidney injury: insights from transcriptomics, network pharmacology, virtual screening, and in vitro experimentsGuoqiang Li, Dianjie Zeng, Yinhuai Wang, et al.
International Journal of Biological Macromolecules|July 19, 2025
Molecular characterization and functional prioritization of CD46, IL6R, KLRC1, LEAP2 and SMOX as candidate targets in acute kidney injuryJiachen Liu, Dianjie Zeng, Yinhuai Wang, et al.
Biology Direct|March 28, 2025
Identification of druggable targets in acute kidney injury by proteome- and transcriptome-wide Mendelian randomization and bioinformatics analysisJiachen Liu, Dianjie Zeng, Yinhuai Wang, et al.
The Oncologist|January 26, 2026
Multidimensional liquid biopsy in bladder cancer: Advances in CTCs, ctDNA, exosomes, and metabolomicsDianjie Zeng, Bojian Liu, Fei Deng, et al.
International Journal of Surgery (London, England)|November 4, 2025
Integrated multi-omics and causal inference framework with experimental validation reveals key drivers of air pollution-induced acute kidney injuryJiachen Liu, Dianjie Zeng, Liangmin Fu, et al.
Plos Computational Biology|April 16, 2026
Systematic prioritization of potential therapeutic targets for glomerulonephritis using multi-omics Mendelian randomizationGuoqiang Li, Fu Jianhan, Jiashu Gu, et al.
Molecular Therapy. Nucleic Acids|June 15, 2026
Cell type-stratified immunogenetic framework reveals immune drivers and therapeutic targets in kidney stone diseaseDianjie Zeng, Lingfei Zhu, Jiachen Liu, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 29, 2026
Mechanism-centered target discovery across glomerulonephritis phenotypes: an integrative multi-omics studyJiachen Liu, Xiaorui Qiu, Dianjie Zeng, et al.
Pageof 1